CSI Market
Sign In | Register

Arbutus Biopharma (ABUS) Annual Balance Sheets

Annual · GAAP · USD millions
Access ABUS quarterly Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Arbutus Biopharma manages assets, liabilities, and equity through different cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent18.01
Short-term Investments, Total0.09
Cash & Short-term Investments18.00
Accounts receivable0.00
Unbilled Receivables, Current RE0.30
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.54
Total Current Assets94.46
Equipment/Property/Plant Net0.21
Long-term investments0.00
Tax Assets, Noncurrent3.38
Other Assets, Noncurrent0.13
Operating Lease Right Of Use Asset-
Total Assets94.62
Liabilities
Accounts Payable and Accrued Liabilities, Current LI5.46
Accrued Liabilities, Current1.08
Other Liabilities, Current0.55
Deferred Revenue, Current DE0.00
Total Current Liabilities6.01
Total Long-term Debt0.00
Restructuring Reserve, Current RE0.64
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent12.04
Operating Lease Liability Current0.55
Employee Stock Options Liability Classified Outstanding-
Liability Related To Sale Of Future Royalties Noncurrent3.44
Total Liabilities18.04
Stockholders' Equity
Common Stock Value1,421.43
Additional Paid In Capital Common Stock83.32
Retained Earnings / Accumulated Deficit-1,380.07
Accumulated Other Comprehensive Income-48.10
Other Equity-48.10
Common Stockholder's Equity76.58
Total Stockholder's Equity76.58
Liabilities & Stockholder's Equity94.62
4 historic quarters locked

Sign in to unlock the full Arbutus Biopharma balance sheet history.

Sign In Create Free Account

About Arbutus Biopharma Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001447028-26-000017

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.